Updated Jul 16, 2026
Karas Eric has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $645K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-13 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale | 25.0K | $10.00 | $250K |
| 2026-06-13 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 25.0K | $1.50 | $38K |
| 2025-07-01 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale | 15.0K | $16.99 | $255K |
| 2025-07-01 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise | 15.0K | $1.50 | $22K |
| 2024-12-04 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 6.3K | $14.00 | $88K |
| 2024-12-04 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 6.3K | $1.50 | $9K |
| 2024-12-04 | SPRY | ARS Pharmaceuticals, Inc. | S — Open-market sale [10b5-1] | 3.7K | $14.11 | $52K |
| 2024-12-04 | SPRY | ARS Pharmaceuticals, Inc. | M — Option exercise [10b5-1] | 3.7K | $1.50 | $6K |
Karas Eric is a corporate insider — currently tracked as Insider of ARS Pharmaceuticals, Inc. (SPRY). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($645K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Karas Eric profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.